Tyr260
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr260  -  ATP1A1 (human)

Site Information
tARGIVVytGDrtVM   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 454981
Available spectra:  1 CST
Associated spectra:  3 CST

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 479 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 736 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 823 , 824 , 825 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 871 , 872 , 873 , 874 , 875 , 876 , 877 , 878 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 994 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1015 , 1016 , 1017 , 1018 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1042 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1067 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1132 , 1133 , 1134 , 1135 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1167 , 1168 , 1169 , 1170 , 1171 , 1172 , 1173 , 1174 , 1175 , 1176 , 1177 , 1178 , 1179 , 1180 , 1181 , 1182 , 1183 , 1184 , 1185 , 1186 , 1187 , 1188 , 1189 , 1190 , 1191 , 1192 , 1193 , 1194 , 1195 , 1196 , 1197 , 1198 , 1199 , 1200 , 1201 )
Disease tissue studied:
adenoid cystic carcinoma ( 493 , 494 ) , bile-duct cancer ( 449 , 452 , 453 , 454 , 486 ) , bladder cancer ( 803 , 804 , 806 , 807 , 867 , 902 ) , bone cancer ( 25 , 641 , 643 , 673 , 674 , 675 , 676 , 1193 ) , Ewing's sarcoma ( 25 , 674 ) , osteosarcoma ( 25 , 641 , 643 , 673 , 675 , 676 , 1193 ) , brain cancer ( 5 , 97 , 98 , 109 , 137 , 310 , 311 , 312 , 313 , 314 , 315 , 528 , 529 , 552 , 553 , 611 , 629 , 688 , 690 , 691 , 815 , 897 , 898 , 1018 , 1019 , 1030 , 1045 , 1046 , 1047 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1063 , 1064 , 1069 , 1078 , 1079 , 1080 , 1102 , 1108 , 1121 , 1162 , 1178 ) , astrocytoma ( 97 , 98 , 109 , 898 , 1063 , 1069 , 1162 , 1178 ) , glioblastoma ( 5 , 137 , 310 , 311 , 312 , 313 , 314 , 315 , 815 , 897 , 1018 , 1019 , 1030 , 1045 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1078 , 1079 , 1080 , 1102 , 1108 , 1121 ) , glioblastoma multiforme ( 528 , 529 , 552 , 553 , 611 , 629 , 688 , 690 , 691 , 897 , 1030 , 1045 , 1055 , 1079 , 1102 , 1108 ) , glioma ( 5 , 137 , 310 , 311 , 312 , 313 , 314 , 315 , 528 , 529 , 552 , 553 , 611 , 629 , 688 , 690 , 691 , 815 , 897 , 1018 , 1019 , 1030 , 1045 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1078 , 1079 , 1080 , 1102 , 1108 , 1121 ) , oligodendroglioma ( 1047 ) , breast cancer ( 7 , 15 , 382 , 383 , 597 , 628 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 796 , 797 , 798 , 799 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 837 , 863 , 864 , 868 , 880 , 903 , 909 , 910 , 920 , 921 , 926 , 929 , 1077 , 1093 , 1094 , 1095 , 1109 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 ) , breast adenocarcinoma ( 863 , 880 , 926 , 1094 , 1156 , 1157 , 1160 , 1161 ) , breast ductal carcinoma ( 1077 , 1095 , 1155 ) , HER2 positive breast cancer ( 2 ) , luminal A breast cancer ( 2 ) , luminal B breast cancer ( 2 ) , breast cancer, surrounding tissue ( 2 ) , breast cancer, triple negative ( 2 , 7 , 830 , 831 , 832 , 833 , 1093 , 1095 , 1109 ) , colorectal cancer ( 25 , 63 , 64 , 65 , 86 , 93 , 94 , 105 , 106 , 155 , 157 , 158 , 159 , 160 , 196 , 515 , 582 , 636 , 637 , 638 , 639 , 681 , 736 , 768 , 769 , 875 , 885 , 937 , 938 , 939 , 943 , 944 , 957 , 992 , 993 , 994 , 1028 , 1029 , 1098 , 1143 , 1144 , 1147 , 1176 , 1177 , 1180 , 1181 ) , colorectal carcinoma ( 25 , 63 , 64 , 65 , 93 , 94 , 105 , 106 , 636 , 637 , 638 , 639 , 681 , 736 , 768 , 769 , 875 , 885 , 937 , 938 , 939 , 943 , 944 , 992 , 993 , 994 , 1028 , 1029 , 1098 , 1143 , 1144 , 1147 , 1176 , 1177 , 1180 , 1181 ) , colorectal cancer, surrounding tissue ( 156 , 161 , 195 , 199 ) , esophageal cancer ( 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 389 , 390 , 393 , 394 , 395 , 398 , 400 , 850 , 851 , 852 , 853 , 886 , 887 , 888 , 904 , 905 , 906 , 907 , 908 , 991 , 1015 , 1016 , 1017 , 1021 , 1022 , 1023 , 1024 , 1025 , 1034 , 1035 ) , esophageal carcinoma ( 203 , 204 , 205 , 206 , 207 , 208 , 209 , 850 , 851 , 852 , 853 , 904 , 905 , 908 , 1021 , 1022 , 1023 , 1024 , 1034 , 1035 ) , esophageal cancer, surrounding tissue ( 388 , 391 , 392 , 396 , 397 , 399 , 402 ) , gallbladder cancer ( 525 ) , gallbladder carcinoma ( 525 ) , gastric cancer ( 22 , 28 , 29 , 30 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 55 , 56 , 57 , 62 , 68 , 69 , 70 , 71 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 95 , 96 , 107 , 108 , 177 , 191 , 192 , 193 , 234 , 235 , 241 , 242 , 246 , 320 , 322 , 323 , 324 , 325 , 499 , 500 , 501 , 502 , 506 , 509 , 511 , 513 , 514 , 517 , 519 , 522 , 599 , 603 , 606 , 607 , 608 , 609 , 610 , 614 , 623 , 624 , 625 , 626 , 630 , 731 , 735 , 848 , 940 , 941 , 942 , 945 , 953 ) , gastric carcinoma ( 28 , 29 , 30 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 55 , 56 , 57 , 62 , 68 , 69 , 70 , 71 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 95 , 96 , 107 , 108 , 177 , 191 , 192 , 193 , 241 , 242 , 246 , 499 , 500 , 501 , 502 , 506 , 509 , 511 , 513 , 514 , 599 , 603 , 610 , 630 , 731 , 735 , 941 ) , gastric carcinoma, surrounding tissue ( 319 , 321 , 326 , 327 , 497 , 498 , 503 , 504 , 505 , 507 , 508 , 510 , 512 , 516 , 518 , 521 , 598 , 605 , 613 ) , kidney cancer ( 642 , 647 , 648 , 802 , 865 ) , kidney cancer, surrounding tissue ( 198 , 335 , 336 , 337 , 338 , 342 , 343 , 344 , 345 , 346 , 348 , 349 ) , leukemia ( 66 , 67 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 194 , 215 , 217 , 218 , 220 , 224 , 225 , 226 , 244 , 247 , 248 , 249 , 250 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 316 , 317 , 318 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 340 , 341 , 368 , 369 , 372 , 373 , 374 , 375 , 379 , 381 , 426 , 427 , 428 , 429 , 430 , 431 , 435 , 436 , 437 , 438 , 590 , 591 , 592 , 593 , 594 , 595 , 600 , 601 , 604 , 612 , 622 , 627 , 665 , 668 , 669 , 670 , 671 , 672 , 677 , 678 , 679 , 680 , 684 , 685 , 712 , 713 , 714 , 718 , 719 , 724 , 732 , 733 , 734 , 737 , 738 , 740 , 741 , 742 , 744 , 790 , 819 , 820 , 824 , 825 , 859 , 860 , 861 , 862 , 873 , 874 , 876 , 877 , 891 , 892 , 931 , 932 , 933 , 936 , 946 , 954 , 958 , 959 , 960 , 963 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1048 , 1049 , 1052 , 1053 , 1060 , 1061 , 1062 , 1070 , 1071 , 1072 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1107 , 1112 , 1113 , 1114 , 1116 , 1125 , 1133 , 1134 , 1136 , 1137 , 1138 , 1140 , 1148 , 1167 , 1168 , 1169 , 1170 , 1171 , 1172 , 1191 , 1192 ) , acute lymphocytic leukemia ( 154 , 859 , 860 , 873 , 874 , 876 , 877 , 954 , 960 , 982 , 983 , 1049 , 1060 ) , acute myelogenous leukemia ( 154 , 684 , 685 , 718 , 719 , 724 , 790 , 861 , 862 , 891 , 892 , 936 , 958 , 959 , 963 , 984 , 985 , 986 , 987 , 997 , 1008 , 1009 , 1010 , 1011 , 1012 , 1013 , 1014 , 1048 , 1052 , 1053 , 1061 , 1062 , 1070 , 1071 , 1072 , 1107 , 1112 , 1113 , 1114 , 1116 , 1133 , 1134 , 1136 , 1137 , 1138 , 1140 , 1148 , 1167 , 1168 , 1169 , 1170 , 1171 , 1172 ) , chronic myelogenous leukemia ( 66 , 67 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 194 , 215 , 217 , 218 , 220 , 224 , 225 , 226 , 244 , 247 , 248 , 249 , 250 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 316 , 317 , 318 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 340 , 341 , 368 , 369 , 372 , 373 , 374 , 375 , 379 , 381 , 426 , 427 , 428 , 429 , 430 , 431 , 435 , 436 , 437 , 438 , 590 , 591 , 592 , 593 , 594 , 595 , 600 , 601 , 604 , 612 , 622 , 627 , 668 , 669 , 670 , 671 , 672 , 677 , 678 , 679 , 680 , 712 , 713 , 714 , 732 , 733 , 734 , 737 , 738 , 740 , 741 , 742 , 744 , 819 , 820 , 824 , 825 , 931 , 932 , 933 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 981 , 988 , 989 , 990 , 995 , 996 , 998 , 999 , 1000 , 1001 , 1003 , 1004 , 1005 , 1006 , 1007 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1125 , 1191 , 1192 ) , liver cancer ( 151 , 200 , 201 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 362 , 363 , 365 , 367 , 370 , 371 , 409 , 410 , 411 , 412 , 413 , 448 , 451 , 482 , 483 , 485 , 526 , 527 , 571 , 575 , 578 , 580 , 616 , 618 , 620 ) , cholangiocellular carcinoma ( 151 , 411 , 575 , 616 ) , cholangiocellular carcinoma, surrounding tissue ( 573 , 615 , 621 ) , hepatocellular carcinoma ( 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 365 , 367 , 370 , 371 , 409 , 412 , 413 , 571 , 578 , 580 , 618 , 620 ) , hepatocellular carcinoma, surrounding tissue ( 359 , 360 , 361 , 364 , 565 , 569 , 570 , 572 , 576 , 579 , 617 , 619 ) , liver cancer, surrounding tissue ( 574 ) , lung cancer ( 4 , 6 , 9 , 10 , 11 , 12 , 13 , 14 , 16 , 17 , 20 , 24 , 31 , 32 , 33 , 34 , 35 , 61 , 87 , 88 , 89 , 90 , 91 , 92 , 99 , 100 , 101 , 102 , 103 , 104 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 127 , 135 , 180 , 214 , 216 , 219 , 221 , 222 , 223 , 228 , 229 , 230 , 238 , 239 , 246 , 290 , 291 , 292 , 295 , 296 , 297 , 299 , 347 , 376 , 377 , 378 , 407 , 408 , 414 , 415 , 425 , 432 , 433 , 434 , 479 , 480 , 481 , 490 , 523 , 524 , 583 , 584 , 602 , 630 , 631 , 632 , 633 , 634 , 635 , 683 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 709 , 710 , 711 , 730 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 785 , 786 , 787 , 793 , 794 , 795 , 805 , 808 , 811 , 834 , 835 , 849 , 869 , 870 , 871 , 872 , 889 , 893 , 894 , 895 , 896 , 912 , 913 , 918 , 919 , 922 , 923 , 924 , 925 , 927 , 928 , 930 , 934 , 935 , 955 , 956 , 961 , 968 , 970 , 980 , 1027 , 1031 , 1032 , 1033 , 1065 , 1067 , 1068 , 1075 , 1076 , 1096 , 1110 , 1111 , 1115 , 1117 , 1118 , 1119 , 1120 , 1122 , 1123 , 1124 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1135 , 1141 , 1142 , 1145 , 1146 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1163 , 1164 , 1165 , 1166 , 1175 , 1179 , 1183 , 1186 , 1187 , 1189 , 1190 , 1195 , 1198 , 1199 ) , non-small cell lung cancer ( 6 , 9 , 10 , 11 , 13 , 14 , 16 , 18 , 19 , 23 , 24 , 31 , 32 , 33 , 34 , 35 , 61 , 87 , 88 , 89 , 90 , 91 , 92 , 99 , 100 , 101 , 102 , 103 , 104 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 127 , 180 , 228 , 229 , 230 , 290 , 291 , 292 , 295 , 296 , 297 , 299 , 347 , 407 , 408 , 414 , 415 , 479 , 480 , 481 , 490 , 583 , 584 , 602 , 630 , 631 , 632 , 633 , 634 , 635 , 683 , 699 , 700 , 701 , 705 , 706 , 707 , 709 , 710 , 711 , 730 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 758 , 759 , 760 , 761 , 762 , 763 , 766 , 767 , 780 , 781 , 782 , 783 , 785 , 786 , 793 , 794 , 795 , 808 , 849 , 869 , 870 , 871 , 872 , 889 , 893 , 894 , 895 , 896 , 919 , 922 , 923 , 924 , 925 , 927 , 928 , 930 , 934 , 935 , 955 , 956 , 961 , 968 , 970 , 980 , 1027 , 1065 , 1067 , 1068 , 1076 , 1096 , 1110 , 1115 , 1117 , 1118 , 1119 , 1120 , 1122 , 1123 , 1124 , 1126 , 1127 , 1128 , 1129 , 1131 , 1135 , 1141 , 1142 , 1145 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1163 , 1166 , 1175 , 1179 , 1186 , 1187 , 1189 , 1190 , 1198 , 1199 ) , non-small cell lung cancer, surrounding tissue ( 231 , 232 , 405 , 491 , 520 , 534 ) , non-small cell lung adenocarcinoma ( 4 , 6 , 9 , 10 , 11 , 12 , 13 , 14 , 16 , 17 , 19 , 20 , 61 , 89 , 90 , 91 , 92 , 101 , 102 , 103 , 104 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 127 , 180 , 290 , 291 , 292 , 295 , 296 , 297 , 299 , 481 , 490 , 583 , 584 , 630 , 705 , 706 , 707 , 710 , 711 , 730 , 811 , 834 , 835 , 918 , 1129 , 1145 , 1152 , 1186 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 126 , 293 , 294 , 298 ) , non-small cell large cell lung carcinoma ( 10 , 13 , 805 ) , non-small cell squamous cell lung carcinoma ( 12 , 246 , 376 , 377 , 378 , 425 , 432 , 433 , 434 , 523 , 524 , 1110 , 1118 , 1141 , 1142 , 1190 , 1199 ) , small-cell lung cancer ( 1031 , 1032 , 1033 , 1075 , 1164 , 1165 , 1183 , 1195 ) , lung cancer, surrounding tissue ( 136 , 197 , 487 ) , lymphoma ( 202 , 843 , 844 , 845 , 846 , 947 , 948 , 949 , 950 , 1036 , 1037 , 1038 , 1040 , 1041 , 1042 , 1043 , 1044 , 1099 , 1100 , 1103 , 1104 ) , anaplastic large cell lymphoma ( 1099 , 1100 , 1103 , 1104 ) , B cell lymphoma ( 1036 , 1037 , 1038 , 1040 , 1041 , 1042 , 1043 , 1044 ) , Hodgkin's lymphoma ( 202 , 843 , 844 , 845 , 846 , 947 , 948 , 949 , 950 ) , neuroblastoma ( 3 , 178 , 179 , 545 , 546 , 547 , 816 , 817 , 818 , 838 , 840 , 841 , 855 , 899 , 900 , 901 , 951 , 1046 , 1064 , 1066 ) , ovarian cancer ( 138 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 211 , 212 , 213 , 233 , 236 , 237 , 240 , 245 , 649 , 650 , 651 , 652 , 654 , 655 , 656 , 657 , 658 , 952 , 962 , 964 , 965 , 966 , 967 , 969 , 1097 ) , ovarian epithelial carcinoma ( 138 , 164 , 167 , 962 ) , pancreatic cancer ( 682 ) , pancreatic carcinoma ( 682 ) , pancreatic ductal adenocarcinoma ( 8 ) , pancreatic cancer, surrounding tissue ( 380 ) , multiple myeloma ( 406 , 915 , 916 , 917 , 1026 , 1039 , 1050 , 1051 , 1132 ) , salivary gland cancer ( 457 , 460 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 ) , melanoma skin cancer ( 277 , 423 , 424 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 450 , 556 , 557 , 558 , 566 , 567 ) , non-melanoma skin cancer ( 1196 , 1197 ) , leiomyosarcoma ( 25 ) , rhabdomyosarcoma ( 25 ) , teratoma ( 227 ) , thymic carcinoma ( 129 , 130 , 131 ) , thyroid cancer ( 890 , 914 , 1139 ) , follicular thyroid carcinoma ( 890 , 914 , 1139 ) , thyroid cancer, surrounding tissue ( 596 ) , ventricular tachycardia ( 132 , 133 , 134 , 139 , 140 , 141 )
Relevant cell line - cell type - tissue:
'liver, para-cholangiocellular carcinoma tissue' ( 151 ) , 'pancreatic, ductal'-pancreas ( 8 ) , 143.98.2 (bone cell) ( 676 ) , 143B (bone cell) ( 643 ) , 184A1 (epithelial) ( 366 , 854 ) , 184A1 (epithelial) [HER2 (human), transfection] ( 854 ) , 23132/87 (gastric) ( 941 ) , 293 (epithelial) ( 404 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 251 ) , 293 (epithelial) [EphB2 (human), transfection] ( 251 ) , 293T (epithelial) ( 458 , 459 , 461 , 462 , 1194 ) , 42-MG-BA (glial) ( 897 , 1045 ) , 44-ZW-5409 (eye cell) ( 691 ) , 47-CD-3188 (glial) ( 688 ) , 56-DT-9110 (glial) ( 690 ) , 5637 (bladder cell) ( 867 ) , 639L (renal) ( 802 ) , 703167 (pulmonary) ( 214 ) , 704773 (pulmonary) ( 216 ) , 8-MG-BA (glial) ( 1055 ) , A172 (glial) ( 1018 ) , A204 (muscle cell) ( 25 ) , A431 (epithelial) ( 1196 , 1197 ) , A498 (renal) ( 883 ) , A549 (pulmonary) ( 9 , 20 , 61 , 583 , 702 , 703 , 704 ) , A673 (muscle cell) ( 25 ) , ACN ( 3 , 840 ) , AGS (gastric) ( 945 ) , AU565 (breast cell) ( 826 , 827 ) , BC-3C (bladder cell) ( 803 ) , BEAS-2B (epithelial) ( 416 , 417 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 418 , 419 ) , bone marrow ( 684 , 685 ) , breast ( 2 , 7 , 597 , 628 , 868 ) , BT-20 (breast cell) ( 697 , 698 ) , BT-474 (breast cell) ( 382 ) , Caki-2 (renal) ( 866 , 881 , 884 ) , Cal-12T (pulmonary) ( 16 ) , CAL-148 (breast cell) ( 903 ) , CAL-29 (bladder cell) ( 807 ) , CAL-51 (breast cell) ( 828 , 829 ) , CAL-85-1 (breast cell) ( 863 , 926 ) , Calu-3 (pulmonary) ( 11 , 1130 ) , Caov-3 (ovarian) ( 969 ) , cardiac-heart ( 139 , 140 ) , CAS-1 (glial) ( 815 ) , cholangiocyte-liver ( 411 , 575 , 616 ) , CHP212 (neural crest) ( 3 , 1046 ) , CHRF (megakaryocyte) ( 1136 ) , CI-1 (B lymphocyte) ( 1040 ) , CMK (megakaryoblast) ( 997 , 1070 , 1071 , 1072 , 1171 ) , CMS (myeloid) ( 861 , 862 ) , COLO-680N (esophageal) ( 210 , 906 , 991 ) , COLO-699 (pulmonary) ( 924 ) , colon ( 155 , 156 , 157 , 158 , 159 , 160 , 161 , 195 , 196 , 199 , 515 , 582 , 681 ) , CTV-1 (myeloid) ( 1107 , 1116 ) , DBTRG-05MG (glial) ( 1102 ) , DK-MG (glial) ( 1030 ) , DLD1 (intestinal) ( 25 , 86 ) , DMS153 (pulmonary) ( 14 , 1073 , 1074 , 1195 ) , DMS53 (pulmonary) ( 1165 ) , DMS79 (pulmonary) ( 1164 ) , DU.528 ('stem, hematopoietic') ( 1049 ) , DU4475 (breast cell) ( 880 ) , DV-90 (pulmonary) ( 913 ) , EFM-19 (breast cell) ( 879 ) , EFM-192A (breast cell) ( 909 ) , EFO-21 (ovarian) ( 964 ) , EFO-27 (ovarian) ( 965 ) , ELF-153 (megakaryocyte) ( 1167 ) , esophagus ( 388 , 389 , 390 , 391 , 392 , 393 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 402 ) , EVSA-T (breast cell) ( 920 ) , FU-OV-1 (ovarian) ( 952 ) , FU97 (gastric) ( 234 , 235 , 608 ) , G-292 (bone cell) ( 673 ) , GAMG (glial) ( 1056 , 1058 ) , GI-CA-N (neural crest) ( 3 , 816 ) , GI-LI-N (neuron) ( 3 , 841 ) , GI-ME-N (neuron) ( 3 , 838 ) , glial-brain ( 5 ) , GMS-10 (glial) ( 1054 ) , GOS-3 (glial) ( 1047 ) , HCC1143 (breast cell) ( 1095 ) , HCC1395 (breast cell) ( 1077 ) , HCC1428 (breast cell) ( 1094 ) , HCC15 (pulmonary) ( 12 , 961 , 968 ) , HCC1599 (breast cell) ( 796 , 797 ) , HCC1806 (breast cell) ( 1109 ) , HCC1937 (breast cell) ( 1093 ) , HCC202 (breast cell) ( 692 ) , HCC366 (pulmonary) ( 1166 ) , HCC38 (breast cell) ( 830 , 831 ) , HCC44 (pulmonary) ( 16 , 1154 ) , HCC70 (breast cell) ( 832 , 833 ) , HCC78 (pulmonary) ( 13 , 91 , 92 , 103 , 104 , 481 , 871 , 1153 ) , HCC827 (pulmonary) ( 11 , 180 , 630 , 705 , 706 , 707 , 730 , 1129 , 1186 ) , HCT116 (intestinal) ( 63 , 64 , 65 , 93 , 94 , 105 , 106 , 736 , 875 , 939 , 1180 , 1181 ) , HCT15 (intestinal) ( 992 ) , HCT8 (intestinal) ( 993 , 994 ) , HD-MyZ (myeloid) ( 844 , 948 ) , HDLM-2 (lymphoid) ( 845 , 947 ) , HDQ-P1 (breast cell) ( 910 ) , heart ( 132 , 133 , 134 , 141 ) , HEL (erythroid) ( 891 , 892 , 986 , 987 , 1106 ) , HeLa (cervical) ( 153 , 243 , 455 , 456 , 531 , 548 , 549 , 550 , 551 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 573 , 615 , 621 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 359 , 360 , 361 , 364 , 565 , 569 , 570 , 572 , 576 , 579 , 617 , 619 ) , hepatocyte-liver ( 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 365 , 367 , 409 , 412 , 413 , 571 , 578 , 580 , 618 , 620 ) , HepG2 (hepatic) ( 371 ) , HES-3 ('stem, embryonic') ( 152 ) , HLF (hepatic) ( 370 ) , HMEC (endothelial) ( 708 ) , Hs683 (glial) ( 1019 ) , HT-29 (intestinal) ( 943 , 944 , 1147 , 1176 , 1177 , 1185 ) , HU-3 (myeloid) ( 1168 ) , Huh28 (hepatic) ( 485 ) , Huh6 (hepatic) ( 526 ) , Huh7 (hepatic) ( 527 ) , HUVEC (endothelial) ( 495 , 496 ) , IM95 (gastric) ( 609 ) , IMR32 (neural crest) ( 3 , 855 ) , J82 (bladder cell) ( 882 ) , JHH-4 (hepatic) ( 448 ) , JHH-6 (hepatic) ( 483 ) , JHH-7 (hepatic) ( 482 ) , JIMT-1 (breast cell) ( 864 , 921 ) , Jurkat (T lymphocyte) ( 72 , 85 , 128 , 339 , 422 , 488 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 554 , 555 , 559 , 560 , 561 , 562 , 563 , 564 , 568 , 577 , 1101 , 1173 , 1174 ) , Jurkat E6-1 (T lymphocyte) ( 21 ) , K562 (erythroid) ( 66 , 67 , 110 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 194 , 215 , 217 , 218 , 220 , 224 , 225 , 226 , 244 , 247 , 248 , 249 , 250 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 271 , 272 , 273 , 274 , 275 , 276 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 300 , 301 , 302 , 303 , 304 , 305 , 306 , 307 , 308 , 309 , 316 , 317 , 318 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 340 , 341 , 368 , 369 , 372 , 373 , 374 , 375 , 379 , 381 , 426 , 427 , 428 , 429 , 430 , 431 , 435 , 436 , 437 , 438 , 530 , 581 , 590 , 591 , 592 , 593 , 594 , 595 , 600 , 601 , 604 , 612 , 622 , 627 , 645 , 646 , 668 , 669 , 670 , 671 , 672 , 677 , 678 , 679 , 680 , 712 , 713 , 714 , 715 , 716 , 717 , 727 , 728 , 729 , 732 , 733 , 734 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 819 , 820 , 824 , 825 , 842 , 847 , 878 , 931 , 932 , 933 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 981 , 988 , 989 , 990 , 995 , 996 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1081 , 1082 , 1083 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1105 , 1125 , 1191 , 1192 ) , Karpas-1106P (B lymphocyte) ( 1044 ) , KATO III (gastric) ( 942 ) , KELLY (neural crest) ( 3 , 951 ) , KG-1 (myeloid) ( 790 , 1061 , 1062 ) , kidney ( 198 , 335 , 336 , 337 , 338 , 342 , 343 , 344 , 345 , 346 , 348 , 349 , 642 , 647 , 648 ) , KMS-11 (B lymphocyte) ( 916 , 917 ) , KOPT-K1 (T lymphocyte) ( 1060 ) , KPL-1 (breast cell) ( 929 ) , KPL-4 (breast cell) ( 15 ) , KY821 (myeloid) ( 154 , 1014 , 1137 ) , Kyse140 (esophageal) ( 207 , 850 , 851 , 852 , 853 , 1023 , 1034 ) , Kyse150 (esophageal) ( 204 ) , Kyse180 (esophageal) ( 209 , 1024 , 1035 ) , Kyse270 (esophageal) ( 886 , 887 , 888 , 1015 ) , Kyse30 (esophageal) ( 203 , 1021 ) , Kyse410 (esophageal) ( 1025 ) , Kyse450 (squamous) ( 1017 ) , Kyse510 (esophageal) ( 206 , 1016 ) , Kyse520 (esophageal) ( 205 , 907 ) , Kyse70 (esophageal) ( 208 , 904 , 905 , 908 , 1022 ) , L1236 (lymphoid) ( 667 ) , L428 (lymphoid) ( 843 , 949 ) , L540 (lymphoid) ( 202 , 846 , 950 ) , LAN-1 (neural crest) ( 3 , 817 ) , LAN-5 (neural crest) ( 3 , 818 ) , LAN-6 (neural crest) ( 3 , 545 , 546 , 547 ) , LCLC-103H (pulmonary) ( 922 ) , liver ( 151 , 200 , 362 , 363 , 410 , 574 ) , LN18 (glial) ( 528 , 529 , 552 , 553 , 611 , 629 , 1079 ) , LN229 (glial) ( 1080 ) , LN405 (glial) ( 898 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFR (wildtype)] ( 137 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII mutant (aka Delta EGFR, d2-7 EGFR; del. exon 2-7; in-frame loss 801 bp/267 aa in EC domain)] ( 137 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII-ki mutant (deletion of exons 2-7 plus kinase inactive mutation)] ( 137 ) , LN444 (glial) ( 310 , 311 , 312 , 313 , 314 , 315 ) , LOU-NH91 (squamous) ( 12 , 1118 ) , lung ( 6 , 9 , 10 , 11 , 12 , 13 , 14 , 16 , 17 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 135 , 136 , 197 , 219 , 221 , 222 , 223 , 228 , 229 , 230 , 231 , 232 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 347 , 376 , 377 , 378 , 405 , 407 , 408 , 425 , 432 , 433 , 434 , 487 , 490 , 491 , 520 , 523 , 524 , 534 , 602 , 631 , 632 , 633 , 634 , 635 , 683 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 785 , 786 , 787 , 793 , 794 , 795 , 869 , 872 , 889 , 893 , 894 , 895 , 896 , 934 , 935 , 1111 , 1115 , 1182 , 1183 ) , LXF-289 (pulmonary) ( 923 ) , M-07e (myeloid) ( 1169 ) , M059J (glial) ( 1078 ) , M059K (glial) ( 1121 ) , Marimo (myeloid) ( 154 , 1012 , 1138 ) , MC-116 (B lymphocyte) ( 1041 ) , MCF-10A (breast cell) ( 169 , 1158 , 1159 ) , MCF-10A (breast cell) [CSFR (human), transfection] ( 169 ) , MCF-7 (breast cell) ( 1156 ) , MDA-MB-361 (breast cell) ( 383 ) , MDA-MB-415 (breast cell) ( 693 , 694 ) , MDA-MB-435S (breast cell) ( 1161 ) , MDA-MB-436 (breast cell) ( 695 , 696 ) , MDA-MB-453 (breast cell) ( 1160 ) , MDAH2774 (ovarian) ( 966 ) , ME-F2 (myeloid) ( 154 , 1013 , 1140 ) , MG63 (bone cell) ( 25 , 641 ) , MHH-CALL4 (B lymphocyte) ( 954 , 960 ) , MHH-NB-11 (neural crest) ( 3 , 899 ) , MKN-1 (gastric) ( 610 ) , MKN-45 (gastric) ( 22 , 28 , 29 , 30 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 55 , 56 , 57 , 62 , 68 , 69 , 70 , 71 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 95 , 96 , 107 , 108 , 177 , 191 , 192 , 193 , 241 , 242 , 246 , 489 , 630 , 731 , 735 , 953 ) , MKN-7 (gastric) ( 624 ) , MKN-74 (gastric) ( 625 ) , MKPL-1 (megakaryoblast) ( 687 , 1172 ) , ML-1 (myeloid) ( 154 , 890 , 914 , 1139 ) , MNNG-HOS (bone cell) ( 25 , 1193 ) , MO-91 (myeloid) ( 1052 , 1053 ) , Molm 14 (myeloid) ( 154 , 1009 , 1133 ) , MT-3 (breast cell) ( 834 , 835 ) , MUTZ-5 (B lymphocyte) ( 859 , 860 ) , MV4-11 (macrophage) ( 154 , 401 , 403 , 723 , 724 , 725 , 726 , 1010 , 1134 ) , myeloid-bone marrow ( 936 , 958 , 959 , 963 ) , N87 (gastric) ( 1184 ) , NALM19 (B lymphocyte) ( 946 ) , NCCIT (epithelial) ( 227 ) , NCI-H1299 (pulmonary) ( 10 , 1119 ) , NCI-H1355 (pulmonary) ( 9 , 912 ) , NCI-H1417 (pulmonary) ( 1031 ) , NCI-H1435 (pulmonary) ( 1096 ) , NCI-H1437 (pulmonary) ( 14 , 16 , 1150 ) , NCI-H1568 (pulmonary) ( 1149 ) , NCI-H157 (pulmonary) ( 24 ) , NCI-H1650 (pulmonary) ( 11 , 31 , 32 , 33 , 34 , 35 , 87 , 88 , 99 , 100 , 630 , 1126 , 1200 ) , NCI-H1651 (pulmonary) ( 955 , 970 , 1120 ) , NCI-H1666 (pulmonary) ( 16 , 24 , 630 , 1128 ) , NCI-H1693 (pulmonary) ( 1123 ) , NCI-H1703 (squamous) ( 12 , 246 , 384 , 385 , 386 , 387 , 484 , 699 , 700 , 701 , 1175 ) , NCI-H1734 (pulmonary) ( 10 , 630 , 1117 ) , NCI-H1781 (pulmonary) ( 13 , 849 ) , NCI-H1792 (pulmonary) ( 9 , 420 , 421 ) , NCI-H1792 (pulmonary) [LKB1 (human), no information] ( 414 , 415 ) , NCI-H1793 (pulmonary) ( 1124 ) , NCI-H1838 (pulmonary) ( 928 , 1068 ) , NCI-H1869 (squamous) ( 1110 ) , NCI-H1944 (pulmonary) ( 10 , 1145 , 1152 ) , NCI-H1975 (pulmonary) ( 11 , 630 , 1127 ) , NCI-H1993 (pulmonary) ( 1189 ) , NCI-H2023 (pulmonary) ( 1122 ) , NCI-H2030 (pulmonary) ( 1076 ) , NCI-H2052 (pulmonary) ( 925 ) , NCI-H2066 (pulmonary) ( 1027 ) , NCI-H2073 (pulmonary) ( 12 , 14 , 930 ) , NCI-H209 (pulmonary) ( 14 ) , NCI-H2106 (pulmonary) ( 11 ) , NCI-H2126 (pulmonary) ( 584 ) , NCI-H2170 (squamous) ( 1190 ) , NCI-H2172 (pulmonary) ( 1135 ) , NCI-H2228 (pulmonary) ( 13 , 19 , 532 , 533 , 535 , 536 , 1065 , 1163 ) , NCI-H226 (pulmonary) ( 1199 ) , NCI-H2286 (pulmonary) ( 1075 ) , NCI-H23 (pulmonary) ( 9 ) , NCI-H2342 (pulmonary) ( 12 , 927 ) , NCI-H2347 (pulmonary) ( 1187 ) , NCI-H2405 (pulmonary) ( 16 ) , NCI-H2452 (pulmonary) ( 919 ) , NCI-H28 (pulmonary) ( 911 ) , NCI-H3122 (pulmonary) ( 13 , 18 , 89 , 90 , 101 , 102 ) , NCI-H3255 (pulmonary) ( 23 , 630 , 870 , 1131 , 1179 ) , NCI-H358 (pulmonary) ( 10 , 479 ) , NCI-H358 (pulmonary) [LKB1 (human), no information] ( 480 ) , NCI-H441 (pulmonary) ( 9 ) , NCI-H446 (pulmonary) ( 1033 ) , NCI-H460 (pulmonary) ( 10 , 1198 ) , NCI-H520 (squamous) ( 1141 , 1142 ) , NCI-H524 (pulmonary) ( 1032 ) , NCI-H596 (pulmonary) ( 956 , 980 , 1067 ) , NCI-H661 (pulmonary) ( 13 , 1146 ) , NCI-H838 (pulmonary) ( 14 , 1151 ) , NCI-H929 (B lymphocyte) ( 406 ) , NKM-1 (myeloid) ( 1011 ) , NOMO-1 (myeloid) ( 154 , 718 , 719 , 1148 ) , NUGC-2 (gastric) ( 623 ) , OCI/AML2 (myeloid) ( 1112 ) , OCI/AML3 (myeloid) ( 154 , 984 , 985 , 1113 ) , OCUG-1 ( 525 ) , OCUM-1 (gastric) ( 606 ) , OPM-1 (B lymphocyte) ( 915 ) , OV90 (ovarian) ( 962 ) , ovary ( 170 , 171 , 172 , 173 , 174 , 211 , 212 , 213 , 233 , 236 , 237 , 240 , 245 , 649 , 650 , 651 , 652 , 654 , 655 , 656 , 657 , 658 ) , OVKATE (ovarian) ( 162 , 165 ) , OVMANA (ovarian) ( 138 , 164 , 167 ) , OVMIU (ovarian) ( 175 ) , OVSAHO (ovarian) ( 166 ) , OZ (bile-duct cell) ( 486 ) , P116 (T lymphocyte) ( 289 ) , P116 (T lymphocyte) [ZAP70 (human), homozygous knockout] ( 289 ) , PA-1 (ovarian) ( 967 ) , pancreas ( 380 , 682 ) , PC9 (pulmonary) ( 4 , 709 , 710 , 711 , 808 ) , PC9-IR (pulmonary) ( 4 , 918 ) , PC9-TAR (pulmonary) ( 811 ) , Pfeiffer (B lymphocyte) ( 1043 ) , PL21 (myeloid) ( 1008 , 1114 ) , RC-K8 (B lymphocyte) ( 1042 ) , RD-ES (bone cell) ( 25 ) , RD18 (muscle cell) ( 25 ) , Reh (B lymphocyte) ( 982 ) , RERF-GC-1B (gastric) ( 607 ) , RI-1 (B lymphocyte) ( 1038 ) , RKO (intestinal) ( 1098 ) , RMUG-S (ovarian) ( 163 , 168 ) , RPMI-8226 (plasma cell) ( 1132 ) , RS4;11 (B lymphocyte) ( 154 , 983 ) , SACC-83 (salivary gland) ( 493 , 494 ) , salivary gland ( 457 , 460 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 ) , Saos-2 (bone cell) ( 25 ) , Scaber (squamous) ( 865 ) , SCH (gastric) ( 626 ) , SEM (B lymphocyte) ( 873 , 874 , 876 , 877 ) , SH-SY5Y (neural crest) ( 3 , 178 , 179 ) , SK-ES-1 ( 674 ) , SK-LMS-1 (muscle cell) ( 25 ) , SK-N-MC (neural crest) ( 3 , 1066 ) , SKBr3 (breast cell) ( 1157 ) , skin ( 277 , 423 , 424 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 450 , 556 , 557 , 558 , 566 , 567 ) , SKNAS (neural crest) ( 3 , 1064 ) , SKNDZ (neural crest) ( 3 , 900 ) , SKNFI (neural crest) ( 3 , 901 ) , SKNSH (neural crest) ( 3 ) , SNB-19 (glial) ( 1057 , 1059 ) , SNU-1079 (hepatic) ( 452 ) , SNU-1196 (hepatic) ( 449 ) , SNU-16 (gastric) ( 940 ) , SNU-308 (bile-duct cell) ( 453 ) , SNU-398 (hepatic) ( 451 ) , SNU-478 (bile-duct cell) ( 454 ) , SNU-5 (gastric) ( 848 ) , SNU-C2B (intestinal) ( 937 , 938 ) , stomach ( 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 516 , 517 , 518 , 519 , 521 , 522 , 598 , 599 , 603 , 605 , 613 , 614 ) , SU-DHL-5 (B lymphocyte) ( 1036 ) , SW1088 (glial) ( 1063 ) , SW1710 (bladder cell) ( 806 ) , SW1783 (glial) ( 1069 ) , SW48 (intestinal) ( 957 ) , SW480 (intestinal) ( 636 , 637 , 638 , 639 , 768 , 821 , 1143 ) , SW620 (intestinal) ( 769 , 822 , 823 , 885 , 1028 , 1029 , 1144 ) , SW780 (bladder cell) ( 804 ) , T1-73 (bone cell) ( 675 ) , T47D (breast cell) ( 1155 ) , T98G (glial) ( 1108 ) , thymus ( 129 , 130 , 131 ) , thyroid ( 596 ) , TS (lymphocyte) ( 1099 , 1100 , 1103 , 1104 ) , TYK-nu (ovarian) ( 176 ) , U-118MG (glial) ( 97 , 98 , 109 , 1178 ) , U2OS (bone cell) ( 25 ) , U87MG (glial) ( 1162 ) , UACC-812 (breast cell) ( 798 , 799 ) , UM-UC-1 (bladder cell) ( 902 ) , UT-7 (myeloid) ( 1170 ) , VACO432 (ovarian) ( 1097 ) , VAL (B lymphocyte) ( 1037 ) , XG2 (B lymphocyte) ( 1039 , 1050 ) , XG5 (B lymphocyte) ( 1051 ) , XG7 (B lymphocyte) ( 1026 ) , Z-55 (myeloid) ( 1048 ) , ZR-75-30 (breast cell) ( 836 , 837 )

Upstream Regulation
Regulatory protein:
CSFR (human) ( 169 )
Treatments:
EGF ( 366 ) , ephrin_B1 ( 251 ) , ephrin_B2 ( 251 ) , HGF ( 86 ) , ischemia ( 7 ) , U0126 ( 21 )

References 

1

Banerjee M, et al. (2018) Na/K-ATPase Y260 Phosphorylation-mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth. Sci Rep 8, 12322
30120256   Curated Info

2

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

3

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

4

Tsai CF, et al. (2015) Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics. Nat Commun 6, 6622
25814448   Curated Info

5

Johnson H, White FM (2014) Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J Proteome Res 13, 4581-93
24927040   Curated Info

6

Yoshida T, et al. (2014) Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20, 4059-74
24919575   Curated Info

7

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

8

Britton D, et al. (2014) Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One 9, e90948
24670416   Curated Info

9

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

10

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

11

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

12

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

13

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

14

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

15

Tzouros M, et al. (2013) Development of a 5-plex SILAC method tuned for the quantitation of tyrosine phosphorylation dynamics. Mol Cell Proteomics 12, 3339-49
23882028   Curated Info

16

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

17

Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96
23911959   Curated Info

18

Rikova K (2013) CST Curation Set: 18450; Year: 2013; Biosample/Treatment: cell line, H3122/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

19

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

20

Johnson H, Lescarbeau RS, Gutierrez JA, White FM (2013) Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion. J Proteome Res 12, 1856-67
23438512   Curated Info

21

Helou YA, Nguyen V, Beik SP, Salomon AR (2013) ERK positive feedback regulates a widespread network of tyrosine phosphorylation sites across canonical T cell signaling and actin cytoskeletal proteins in Jurkat T cells. PLoS One 8, e69641
23874979   Curated Info

22

Rikova K (2012) CST Curation Set: 16137; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

23

Rikova K (2012) CST Curation Set: 16138; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

24

Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68
22617229   Curated Info

25

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

26

Rikova K (2012) CST Curation Set: 14270; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 1mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

27

Rikova K (2012) CST Curation Set: 14271; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 2mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

28

Mulhern D (2012) CST Curation Set: 14193; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

29

Zhou J (2012) CST Curation Set: 14105; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

30

Zhou J (2012) CST Curation Set: 14107; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

31

Possemato A (2012) CST Curation Set: 14061; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

32

Possemato A (2012) CST Curation Set: 14062; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

33

Possemato A (2012) CST Curation Set: 14063; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

34

Possemato A (2012) CST Curation Set: 14058; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

35

Possemato A (2012) CST Curation Set: 14059; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

36

Zhou J (2012) CST Curation Set: 14007; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

37

Zhou J (2012) CST Curation Set: 14008; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

38

Zhou J (2012) CST Curation Set: 14009; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

39

Zhou J (2012) CST Curation Set: 14010; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

40

Zhou J (2012) CST Curation Set: 13888; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

41

Zhou J (2012) CST Curation Set: 13889; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

42

Zhou J (2012) CST Curation Set: 13898; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

43

Zhou J (2012) CST Curation Set: 13899; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

44

Zhou J (2012) CST Curation Set: 13884; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

45

Zhou J (2012) CST Curation Set: 13885; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

46

Zhou J (2012) CST Curation Set: 13886; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

47

Zhou J (2012) CST Curation Set: 13887; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

48

Mulhern D (2012) CST Curation Set: 13932; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

49

Mulhern D (2012) CST Curation Set: 13933; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

50

Zhou J (2012) CST Curation Set: 13838; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

51

Zhou J (2012) CST Curation Set: 13839; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

52

Zhou J (2012) CST Curation Set: 13840; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

53

Zhou J (2012) CST Curation Set: 13841; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

54

Rikova K (2012) CST Curation Set: 13730; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 2/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

55

Zhou J (2012) CST Curation Set: 13689; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

56

Zhou J (2012) CST Curation Set: 13690; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

57

Zhou J (2012) CST Curation Set: 13691; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

58

Possemato A (2012) CST Curation Set: 13558; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

59

Possemato A (2012) CST Curation Set: 13559; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

60

Possemato A (2012) CST Curation Set: 13560; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Rikova K (2012) CST Curation Set: 13324; Year: 2012; Biosample/Treatment: cell line, A549/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

62

Rikova K (2012) CST Curation Set: 13326; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

63

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

64

Mulhern D (2012) CST Curation Set: 13332; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

65

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

66

Zhou J (2011) CST Curation Set: 12806; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

67

Zhou J (2011) CST Curation Set: 12808; Year: 2011; Biosample/Treatment: cell line, K-562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

68

Mulhern D (2011) CST Curation Set: 12645; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

69

Mulhern D (2011) CST Curation Set: 12853; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

70

Mulhern D (2011) CST Curation Set: 12854; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

71

Mulhern D (2011) CST Curation Set: 12855; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

72

Mulhern D (2011) CST Curation Set: 12643; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Moritz A (2011) CST Curation Set: 12514; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

74

Moritz A (2011) CST Curation Set: 12515; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Moritz A (2011) CST Curation Set: 12516; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Moritz A (2011) CST Curation Set: 12517; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

Moritz A (2011) CST Curation Set: 12518; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

78

Moritz A (2011) CST Curation Set: 12519; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

79

Moritz A (2011) CST Curation Set: 12369; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

80

Moritz A (2011) CST Curation Set: 12370; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

81

Moritz A (2011) CST Curation Set: 12371; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Moritz A (2011) CST Curation Set: 12374; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Moritz A (2011) CST Curation Set: 12258; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Organ SL, et al. (2011) Quantitative Phospho-Proteomic Profiling of Hepatocyte Growth Factor (HGF)-MET Signaling in Colorectal Cancer. J Proteome Res 10, 3200-11
21609022   Curated Info

87

Possemato A (2011) CST Curation Set: 11905; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Possemato A (2011) CST Curation Set: 11906; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Possemato A (2011) CST Curation Set: 11907; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

91

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

92

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

93

Possemato A (2011) CST Curation Set: 11911; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

94

Possemato A (2011) CST Curation Set: 11912; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

95

Possemato A (2011) CST Curation Set: 11913; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

96

Possemato A (2011) CST Curation Set: 11914; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

97

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

99

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

100

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

101

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

102

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

103

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

104

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

105

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

106

Possemato A (2011) CST Curation Set: 11924; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

107

Possemato A (2011) CST Curation Set: 11925; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

108

Possemato A (2011) CST Curation Set: 11926; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

109

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

110

Artemenko KA, et al. (2011) Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry. Analyst 136, 1971-8
21403953   Curated Info

111

Ren H (2011) CST Curation Set: 11772; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

112

Ren H (2011) CST Curation Set: 11773; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

113

Ren H (2011) CST Curation Set: 11774; Year: 2011; Biosample/Treatment: cell line, RP91/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

Ren H (2011) CST Curation Set: 11775; Year: 2011; Biosample/Treatment: cell line, RP92/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

115

Ren H (2011) CST Curation Set: 11777; Year: 2011; Biosample/Treatment: cell line, RP94/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

116

Ren H (2011) CST Curation Set: 11778; Year: 2011; Biosample/Treatment: cell line, RP95/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

117

Ren H (2011) CST Curation Set: 11780; Year: 2011; Biosample/Treatment: cell line, RP97/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

118

Ren H (2011) CST Curation Set: 11781; Year: 2011; Biosample/Treatment: cell line, RP98/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

119

Ren H (2011) CST Curation Set: 11782; Year: 2011; Biosample/Treatment: cell line, RP99/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

120

Ren H (2011) CST Curation Set: 11783; Year: 2011; Biosample/Treatment: cell line, RP100/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

121

Ren H (2011) CST Curation Set: 11784; Year: 2011; Biosample/Treatment: cell line, RP101/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

122

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

123

Ren H (2011) CST Curation Set: 11786; Year: 2011; Biosample/Treatment: cell line, RP103/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

124

Ren H (2011) CST Curation Set: 11787; Year: 2011; Biosample/Treatment: cell line, RP104/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Ren H (2011) CST Curation Set: 11788; Year: 2011; Biosample/Treatment: cell line, RP105/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

126

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

127

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

128

Possemato A (2011) CST Curation Set: 11711; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

129

Li Y (2011) CST Curation Set: 10458; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

130

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

131

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

132

Li Y (2011) CST Curation Set: 10514; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

Li Y (2011) CST Curation Set: 10515; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

134

Li Y (2011) CST Curation Set: 10527; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

135

Tucker M (2011) CST Curation Set: 10948; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

136

Tucker M (2011) CST Curation Set: 10949; Year: 2011; Biosample/Treatment: tissue, lung/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

137

Chumbalkar V, et al. (2011) Analysis of Phosphotyrosine Signaling in Glioblastoma Identifies STAT5 as a Novel Downstream Target of ΔEGFR. J Proteome Res 10, 1343-52
21214269   Curated Info

138

Ren H (2011) CST Curation Set: 11303; Year: 2011; Biosample/Treatment: cell line, OVMANA/serum starved; Disease: ovarian epithelial carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

139

Li Y (2011) CST Curation Set: 10447; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

140

Li Y (2011) CST Curation Set: 10448; Year: 2011; Biosample/Treatment: heart, cardiac/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

141

Li Y (2011) CST Curation Set: 10502; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

142

Moritz A (2011) CST Curation Set: 11304; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

143

Moritz A (2011) CST Curation Set: 11305; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

144

Moritz A (2011) CST Curation Set: 11306; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

Moritz A (2011) CST Curation Set: 11307; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

Moritz A (2011) CST Curation Set: 11308; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

Moritz A (2011) CST Curation Set: 11309; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

148

Moritz A (2011) CST Curation Set: 11310; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

149

Moritz A (2011) CST Curation Set: 11311; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

150

Moritz A (2011) CST Curation Set: 11312; Year: 2011; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

151

Gu TL, et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 6, e15640
21253578   Curated Info

152

Ding VM, et al. (2011) Tyrosine phosphorylation profiling in fgf-2 stimulated human embryonic stem cells. PLoS One 6, e17538
21437283   Curated Info

153

Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5
21712546   Curated Info

154

Gu TL, et al. (2011) Survey of activated FLT3 signaling in leukemia. PLoS One 6, e19169
21552520   Curated Info

155

Tucker M (2010) CST Curation Set: 10848; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

Tucker M (2010) CST Curation Set: 10847; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

Tucker M (2010) CST Curation Set: 10846; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

Tucker M (2010) CST Curation Set: 10850; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

Tucker M (2010) CST Curation Set: 10856; Year: 2010; Biosample/Treatment: tissue, colon/untreated; Disease: colorectal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

160

Tucker M (2010) CST Curation Set: 10854; Year: 2010; Biosample/Treatment: tissu